Investigation Launched Into Maravai LifeSciences Over Financial Reporting Issues

Glancy Prongay & Murray LLP, a prominent national law firm focused on shareholder rights, has initiated an investigation on behalf of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) MRVI investors. The inquiry will examine potential violations of federal securities laws by the Company.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Company’s Recent Financial Challenges

On February 25, 2025, Maravai announced that it would delay its earnings release and would not be able to submit its annual financial report on time. The Company cited the need for additional time to “complete its assessment of a potential non-cash impairment charge related to goodwill associated with its previous acquisition of Alphazyme LLC.” They also mentioned needing to evaluate an error that led to approximately $3.9 million in revenue being recorded inappropriately—stating that revenue recognized in the last week of Q2 2024 should have been logged in the first week of Q3 2024.

The announcement resulted in a significant decrease in Maravai’s stock price, which fell by $0.87, or 21.7%, ending the day at $3.14 per share, adversely affecting investors.

How to Get Involved or Seek More Information

Investors interested in learning more about this investigation or who have questions regarding their rights in connection with these events are encouraged to get in touch with Glancy Prongay & Murray LLP.

Charles Linehan, Esq.
Glancy Prongay & Murray LLP
1925 Century Park East, Suite 2100
Los Angeles, California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com
Follow us for updates on LinkedIn, Twitter, or Facebook.

Whistleblower Information

Individuals with non-public information about Maravai may be able to assist the investigation or participate in the SEC Whistleblower Program. This program allows whistleblowers to receive rewards of up to 30 percent of any successful recovery by the SEC. For inquiries regarding this program, contact Charles H. Linehan at 310-201-9150 or 888-773-9224, or email [email protected].

About Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP (“GPM”) is a distinguished law firm representing investors and consumers in securities litigation and complex class action cases. GPM has consistently ranked among the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services and was recognized in 2018 as a top five firm for the number of securities class action settlements, alongside being a top six firm for total settlement value.

With four offices nationwide, GPM’s nearly 40 attorneys have secured groundbreaking rulings and recovered billions for clients in various sectors, including securities, antitrust, consumer rights, and employment. The firm has received media coverage from major publications like The Wall Street Journal, The Financial Times, Bloomberg Businessweek, and Reuters.

This press release may be considered Attorney Advertising under applicable laws and ethical guidelines in certain jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250226445609/en/

Glancy Prongay & Murray LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com